There are 2789 resources available
1145P - Reliable detection of BRCA1 and BRCA2 large genomic rearrangements in FFPE tissue: A new diagnostic benchmark for somatic BRCA testing
Presenter: Nadejda Valtcheva
Session: ePoster Display
1072P - Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome
Presenter: Emilia Cocorocchio
Session: ePoster Display
1073P - Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial
Presenter: Sapna Patel
Session: ePoster Display
1074P - Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile
Presenter: Michele Del Vecchio
Session: ePoster Display
1075P - Regression tree analysis to identify factors associated with relapse-free survival (RFS) in patients with resected stage III BRAF V600E/K–mutant melanoma
Presenter: Caroline Robert
Session: ePoster Display
1076P - Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
Presenter: Mehmet Alpaslan Ozgun
Session: ePoster Display
1077P - Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) undergoing systemic therapy: A systematic literature review (SLR) and meta-analysis (MA) of real-world evidence (RWE)
Presenter: Georgina Long
Session: ePoster Display
1078P - Real-world data on patients with melanoma brain metastases and outcome related to locoregional treatment modalities and systemic therapy
Presenter: Sidsel Pedersen
Session: ePoster Display
1080P - HORIZON: Final results from a 5-year ambispective study of 705 patients who initiated pembrolizumab for advanced melanoma in the French early access program
Presenter: Jean Jacques Grob
Session: ePoster Display